Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

CLAW Applauds Los Angeles for Discontinuing Second Generation Rodenticide Poison in All of Its 439 Parks & Wilderness Areas; Policy Shift in Name of Wildlife Protection
  • USA - English


News provided by

Citizens for Los Angeles Wildlife

Oct 24, 2014, 11:30 ET

Share this article

Share toX

Share this article

Share toX

Bobcat succumbed to secondary anti-coagulant rodenticide poisoning
Bobcat succumbed to secondary anti-coagulant rodenticide poisoning

Los Angeles, CA (PRWEB) October 24, 2014 -- Citizens for Los Angeles Wildlife (CLAW), a wildlife and environmental charity organization, applauds the Los Angeles Department of Recreation and Parks for its proactive step to phase out its use of second generation rodenticide in all of the city’s parks and wilderness areas due, in part, to CLAW’s campaign to stop the high rate of unintentional poisoning of wildlife and pets. (KPCC Radio, October 21, 2014)

“Wildlife is the barometer of the health of our environment,” said Alison Simard, Chair, Citizens for Los Angeles Wildlife.

Post this

“We have removed second generation rodenticides from all of our facilities as a policy decision in response to the motion brought forth and in review of our integrated pest management program,” said Laura Bauernfeind, principle ground maintenance supervisor for the City of Los Angeles Department of Recreation and Parks.

The announcement was made in the latest Arts, Parks, Health, Aging and the Los Angeles River (APHAR) Committee meeting called by the Los Angeles City Council. The motion for the report was co-authored by Councilmembers Paul Koretz and Tom LaBonge (seconded by Councilmember Mitch O’Farrell who chairs the APHAR committee) in November 2013 in response to CLAW’s concerns about increasing numbers of Los Angeles cougars, bobcats, coyotes, hawks and owls dying from anti-coagulant rodenticides.

“Wildlife is the barometer of the health of our environment,” said Alison Simard, Chair, Citizens for Los Angeles Wildlife. “We are delighted by this bold response to citizens’ concerns and look forward to continue to work with the City of Los Angeles to educate residents about the horrible effects of using anticoagulant poison – especially those who live in hillsides and near open spaces and parks.”

On March 20, 2014 NBC News was among the media that reported that the State of California banned second generation anticoagulant rodenticides and the consumer products would be removed from store shelves in July 2014. However, both generations of the poison are still available to licensed pest control companies and state agencies. Bauernfeind explained that the department is compelled by LA County of Health to control ground squirrels at their facilities and will continue to use squirrel bait with an active ingredient that is first generation rodenticide but that they will continue to seek alternate non-toxic methods. “We are open to any or every possibility to avoid the use of rodenticides,” she stated.

The matter made national news (LA Times 4/16/14) when the National Park Service and UCLA biologists studying bobcats and mountain lions discovered that Griffith Park resident cougar, P-22, was sick from mange as a direct result of ingesting anticoagulant rodenticides in its prey. “P-22 suffered collateral damage of a public negligence in the way we traditionally handled rodent control. Behind him are, unfortunately, countless numbers of anonymous wildlife that ate poisoned prey and died unceremoniously. This majestic animal served as a symbol of this wildlife devastation,” said Alison Simard.

In April 2014, soon after the news of P-22, Committee Chair Councilmember Mitch O’Farrell moved the motion forward by requesting the Department of Recreation and Parks’ return with reports of how they might reduce or even stop using the dangerous poisons in their pest management systems. Councilmember Paul Koretz attended and gave testimonial during these special sessions to encourage changes that would benefit wildlife.

“I am extremely impressed that the Department of Recreation and Parks has self-imposed this policy in Los Angeles, one of the largest municipal park departments in the United States. This particular policy shift stands as an example around the world of how a major urban city department recognizes the fragility of wildlife in a city’s open space and is working toward a goal of sustainability even if it takes three decades. This is why I took quick measures to address CLAW’s concerns. And I think the Department heard us and made swift policy changes,” said Councilmember Paul Koretz.

Following the report, Councilmember O’Farrell encouraged the on-going search for alternate integrated pest management systems and technology that reduce suffering, and encourage a return to healthy thriving wildlife populations. “We look forward to hearing an updated report in July 2015. That will be one year after the State of California removed second generation rodenticide from consumer shelves and more than a year since the department stopped using it in our natural parks and wilderness areas,” said Councilmember O’Farrell.

After CLAW’s initiation of this cause, support for the Koretz-LaBonge-O’Farrell motion included hundreds of letters, as well as scores of in-person testimonials, from citizens, scientists, and local and national advocacy groups, along with a petition of more than 2,300 signatures. CLAW will continue to encourage the City to discontinue all use of anti-coagulant rodenticides.

About Citizens for Los Angeles Wildlife, Inc. (CLAW):
Citizens for Los Angeles Wildlife, Inc. (CLAW) is a public benefit 501(c)3 non-profit environmental organization. CLAW works to protect and restore the environments of Los Angeles and California from dwindling open spaces. Our mission is to promote, educate and protect the fundamental important of wildlife, wildlife habitats and wildlife corridors everywhere. For more information - visit our website http://www.clawonline.org

Watch our educational videos to learn more about CLAW's work to protect wildlife and wildlife habitats.

Alison Simard, Citizens for Los Angeles Wildlife, http://www.clawonline.org, +1 805-225-4766, [email protected]

Modal title

CLAW letter to Councilmember Paul Koretz
View PDF
CLAW letter to Councilmember Paul Koretz
Sick and Dying Animals in Hollywood Hills
Sick and Dying Animals in Hollywood Hills
Secondary poisoning of untargeted species.
Secondary poisoning of untargeted species.
CLAW letter to Councilmember Paul Koretz Sick and Dying Animals in Hollywood Hills Secondary poisoning of untargeted species.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.